Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nasser Hanna, M.D.
Hoosier Cancer Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Fort Wayne Oncology & Hematology, Inc.
Fort Wayne, Indiana, United States
- Iu Health Goshen Hospital
Goshen, Indiana, United States
- Community Regional Cancer Care
Indianapolis, Indiana, United States
- Iu Health Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Horizon Oncology Research, Inc.
Lafayette, Indiana, United States
- Iu Health Arnett Cancer Center
Lafayette, Indiana, United States
- Iu Health at Ball Memorial Hospital
Muncie, Indiana, United States
- Oncology Hematology Associates of Sw Indiana
Newburgh, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Nebraska Cancer Specialists
Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Mar 2015
- Primary completion
- 10 Aug 2020
- Completion
- 1 Jan 2021
- Last update posted
- 13 Sept 2023
- Registered enrollment
- 93
- Registry id
- NCT02343952
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.